Cell line · CVCL_1682
SCC-25
Cancer cell line, Homo sapiens. Tongue squamous cell carcinoma. 71 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. SCC-25. Cell lines, record CVCL_1682. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1682
On this page
Cell line
As Cellosaurus gives it.
- Name
- SCC-25
- Accession
- CVCL_1682
- RRID
- RRID:CVCL_1682
- Synonyms
- SCC 25, SCC25, hSCC-25
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 70Y
- Category
- Cancer cell line
- Diseases
- Tongue squamous cell carcinoma (NCIt C4648); Squamous cell carcinoma of the oral tongue (ORDO Orphanet_457252)
- Derived from
- Oral cavity, tongue (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers71
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Dual targeting of ACSS2 and ACLY by a novel inhibitor S8588 suppresses oncogenic lipogenesis and overcomes metabolic compensation in oral squamous cell carcinoma. | Int J Oral Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Oral Fungal Infection Impacts Epithelial Innate Immunity to Promote Local and Distal Squamous Cell Carcinoma Progression. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Antitumor Activity of Combined Topoisomerase Inhibition and FLASH Radiotherapy in Head and Neck Carcinoma Biomodels. | MedComm (2020) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cysteine suppresses the progression of oral squamous cell carcinoma via regulating GLDC. | Transl Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Serum metabolomics profiling in head and neck squamous cell carcinoma: a multicentre diagnostic study. | EBioMedicine | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Newly identified invasion drivers define the tumor front in oral squamous cell carcinoma. | Cell Death Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Maackia amurensis seed lectin inhibits oral squamous cell carcinoma tumorigenesis by suppressing N6-methyladenosine modification-mediated SRY-box transcription factor 2 expression. | J Int Med Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Astragaloside IV represses the immune evasion and acidic microenvironment of oral squamous cell carcinoma. | Cell Mol Biol Lett | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The PI3K Inhibitor HCD Promotes Caspase Activation in Head and Neck Squamous Cells by Upregulating the Extrinsic and Intrinsic Apoptosis Pathways. | J Oral Pathol Med | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 71
See all 71 papersRelatives6
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE SCC-25-Cas9 | CVCL_F5PI | Cell lines | |
| Derived from it | EDITGENE SCC-25-CopGFP | CVCL_F5ZF | Cell lines | |
| Derived from it | EDITGENE SCC-25-FLUC | CVCL_F5RY | Cell lines | |
| Derived from it | ER-SCC-25 | CVCL_EI28 | Cell lines | |
| Derived from it | HyCyte SCC-25 stable cell line for hSTK3 overexpression | CVCL_F4WD | Cell lines | |
| Derived from it | SCC-25/CP | CVCL_A5BQ | Cell lines |
Cell banks6
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1682
GET https://conductscience.org/api/cell-lines/v1/CVCL_1682/papers?page=2